Newsroom

RICHARDSON, Texas--(BUSINESS WIRE)--Aurora Networks—a Vistance Networks (NASDAQ: VISN) business—and HUBER+SUHNER collaborate on next-gen Remote PHY solution for Vodafone Germany network....

CAPE TOWN, South Africa--(BUSINESS WIRE)--KnowBe4, the world-renowned platform that comprehensively addresses human and agentic AI risk management, today announced the launch of its Phish Alert Button (PAB) for Microsoft Teams. This marks a significant milestone in collaboration security as KnowBe4 brings the same one-click incident response capabilities previously exclusive to email, directly into the platform where employees communicate and collaborate every day. “Cybercriminals are no longer...

LIESTAL, Switzerland--(BUSINESS WIRE)--Curatis Holding AG (SIX:CURN, “Curatis”) reports business revenues of CHF 10.8m (+57%) for 2025. Curatis AG increased sales in its distribution business organically by 13%, from CHF 9.5m to CHF 10.8m. The net result improved from a loss of CHF 4.3m in 2024 to a loss of CHF 1.4m in 2025. Further key statements In September 2025, our development plan for corticorelin was validated at a meeting with the FDA, enabling Curatis to proceed toward a regulatory sub...

ÁMSTERDAM--(BUSINESS WIRE)--Avanzanite Bioscience B.V., una empresa farmacéutica europea especializada en enfermedades raras que se encuentra en fase comercial y está experimentando un rápido crecimiento, ha anunciado hoy su expansión a Francia, la segunda economía más grande de Europa, así como el nombramiento de Constance Sabbagh como directora general para Francia. Tras una inversión de 32 millones de euros en la ronda de financiación de serie A por parte de MVM PartnersMVM Partners, anuncia...

AMSTERDAM--(BUSINESS WIRE)--Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today announced its expansion into France, Europe’s second largest economy, and the appointment of Constance Sabbagh as General Manager, France. Following a €32 million Series A investment by MVM Partners announced in November 2025, Avanzanite is scaling its European infrastructure into a single, integrated platform across 32 countries –...

AMSTERDAM--(BUSINESS WIRE)--Avanzanite Bioscience B.V., (Avanzanite), société pharmaceutique européenne spécialisée dans les maladies rares en pleine croissance, annonce ce jour son développement en France, deuxième plus grande économie d’Europe, et nomme Constance Sabbagh au poste de Directrice Générale France. Suite à sa levée de série A de 32 millions d'euros réalisée auprès de MVM Partners (MVM) en novembre 2025, Avanzanite assure ainsi la montée en puissance de son infrastructure européenn...

AMSTERDAM--(BUSINESS WIRE)--Avanzanite Bioscience B.V., ein schnell wachsendes europäisches Pharmaunternehmen im kommerziellen Stadium, dessen Schwerpunkt auf seltenen Krankheiten liegt, gab heute seine Expansion nach Frankreich, der zweitgrößten Volkswirtschaft Europas, sowie die Ernennung von Constance Sabbagh zum General Manager für Frankreich bekannt. Im Anschluss an eine im November 2025 angekündigte Serie-A-Finanzierung in Höhe von 32 Millionen Euro durch MVM Partners skaliert Avanzanite...

AMSTERDAM--(BUSINESS WIRE)--Avanzanite Bioscience B.V., een snelgroeiend Europees farmaceutisch speciaalbedrijf in de commerciële fase dat zich richt op zeldzame ziekten, heeft vandaag de uitbreiding naar Frankrijk – de op één na grootste economie van Europa – aangekondigd, evenals de benoeming van Constance Sabbagh tot General Manager voor Frankrijk. In navolging van een Series A-investering van € 32 miljoen door MVM Partners, die in november 2025 werd aangekondigd, schaalt Avanzanite zijn Eur...

AMSTERDAM--(BUSINESS WIRE)--Avanzanite Bioscience B.V., azienda farmaceutica europea in rapida crescita specializzata nelle malattie rare, oggi ha annunciato la propria espansione in Francia, la seconda maggior economia di tutta Europa, e la nomina della signora Constance Sabbagh a direttore generale per la Francia. A seguito di un investimento di serie A da 32 milioni di euro da parte di MVM Partners, annunciato nel mese di novembre 2025, Avanzanite è impegnata nella trasformazione della propr...

ZUG, Switzerland--(BUSINESS WIRE)--Galderma (SIX: GALD), the pure-play dermatology category leader, will present the latest updates on its innovations across its broad portfolio at the 2026 American Academy of Dermatology (AAD) Annual Meeting, taking place from March 27-31 in Denver, Colorado. Twenty-two abstracts will be presented, including late-breaking data and three oral presentations spanning Therapeutic Dermatology, Injectable Aesthetics, and Dermatological Skincare.               “Galde...